Clinical trial
Predicting Readmissions Using Omics, Biostatistical Evaluate and Artificial Intelligence
NCT05028686 is registered in ClinicalTrials.gov with Institute for Clinical Evaluative Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Predicting Readmissions Using Omics, Biostatistical Evaluate and Artificial Intelligence
- Lead sponsor
- Institute for Clinical Evaluative Sciences
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- February 1, 2019
- Completion date
- September 30, 2029
- Enrollment
- 500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.